AI Achieves Breakthrough in Early Disease Detection

New tool identifies cancer and viral infections at nanoscale, paving the way for improved diagnostics and personalized treatments.

Researchers developed AINU, an AI that distinguishes cancer cells from normal cells and detects early viral infections.
The AI uses high-resolution STORM microscopy to identify cellular changes at a nanoscale level, undetectable by traditional methods.
AINU's accuracy could enable faster, more precise disease monitoring and treatment personalization.
Challenges remain in adapting STORM imaging for clinical settings due to equipment and scalability issues.
The technology also shows promise in enhancing stem cell research by accurately identifying pluripotent cells.